We are live on
!
Find out more
Takeda Pharmaceutical
312 hedge funds and large institutions have $1.76B invested in Takeda Pharmaceutical in 2020 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 87 increasing their positions, 101 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% less call options, than puts
Call options by funds: $46.4M | Put options by funds: $54.9M
30% less capital invested
Capital invested by funds: $2.53B → $1.76B (-$770M)
37% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 59
Holders
312
Holding in Top 10
8
Calls
$46.4M
Puts
$54.9M
Top Buyers
| 1 | +$31.8M | |
| 2 | +$31.3M | |
| 3 | +$26.4M | |
| 4 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
+$24M |
| 5 |
Morgan Stanley
New York
|
+$15.3M |
Top Sellers
| 1 | -$193M | |
| 2 | -$30.7M | |
| 3 | -$22.8M | |
| 4 |
Goldman Sachs
New York
|
-$22.2M |
| 5 |
TAL
TIG Advisors LLC
New York
|
-$21.2M |